About Photopharmics
Photopharmics is a private company based in Lehi, Utah. It has reported $44,788,428 raised in eight offerings on Form D since November 2012. Its chief executive is Kent Savage.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Oct 31, 2023 | Nov 1, 2023amended Nov 3, 2025 | $26,195,278of $26.2M target | 47 | $557K | EquityRule 506(b) | Form D/A ↗2 earlier filings |
| Dec 4, 2020 | Dec 11, 2020 | $2,500,000fully sold | 9 | $277K | Debt, OptionsRule 506(b) | Form D ↗ |
| Sep 27, 2019 | Oct 11, 2019 | $6,644,601fully sold | 24 | $276K | EquityRule 506(b) | Form D ↗ |
| Feb 24, 2017 | Mar 7, 2017 | $2,650,566of $2.7M target | 18 | $147K | DebtRule 506(b) | Form D ↗ |
| Jan 31, 2017 | Feb 10, 2017 | $2,327,991fully sold | 15 | $155K | EquityRule 506(b) | Form D ↗ |
| Jun 12, 2015 | Jul 16, 2015 | $2,060,000of $2.7M target | 15 | $137K | DebtRule 506(b) | Form D ↗ |
| Dec 27, 2012 | Jan 8, 2013 | $2,079,992of $3.1M target | 13 | $159K | Equity06 | Form D ↗ |
| Oct 31, 2012 | Nov 14, 2012 | $330,000fully sold | 7 | $47,143 | Debt06 | Form D ↗ |
| Total, eight offerings | $44,788,428 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Photopharmics's Form D filed Nov 3, 2025.
Earlier filings also listed Ted Stanley (director, last listed Mar 2017) and Henry, Jr. Savage (executive officer and director, last listed Jan 2013).